Survodutide (BI 456906) - dual GLP-1R/glucagon receptor co-agonist for NASH, liver fat reduction, and energy expenditure pathway research.
Survodutide (BI 456906) is a dual GLP-1 receptor/glucagon receptor co-agonist derived from an oxyntomodulin scaffold with fatty acid conjugation for extended half-life. The combination of GLP-1R (satiety, insulin secretion) and GcgR (hepatic glucose production, thermogenesis, energy expenditure) activity in a single molecule provides unique tools for dissecting the contribution of each axis in metabolic research.
SPPS synthesis; HPLC >=99%; LC-MS confirmed; endotoxin tested. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Survodutide |
| CAS Number | 2361542-99-4 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 4,133.58 g/mol |
| Molecular Formula | C183H290N48O60 |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 5 mg · 10 mg · 30 mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.